C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2001
11/28/2001	CN1323813A New polypeptide-neural syndesis ion channel related protein 11 and polynucleotides for coding same
11/28/2001	CN1323812A New polypeptide-human interleukin-13 (IL-13) receptor 11 and polynucleotides for coding same
11/28/2001	CN1323811A New polypeptide-human tumor suppressor factor DPC4 protein 9 and polynucleotides for coding same
11/28/2001	CN1323810A New polypeptide-human mitochon dria carrier protein 13 and polynucleotide for coding same
11/28/2001	CN1323809A New polypeptide-human uteroglobin 12 and polynucleotide for coding same
11/28/2001	CN1323808A New polypeptide-human sec 13-related protein 10 and polynucleotides for coding same
11/28/2001	CN1323807A New polypeptide-human phosphoryl transport protein 12 and polynucleotides for coding same
11/28/2001	CN1323806A New polypeptide-human neural cell adhesion protein 31 and polynucleotides for coding same
11/28/2001	CN1323805A New polypeptide-human zinc finger protein 15 and polynucleotides for coding same
11/28/2001	CN1323804A New polypeptide-human ribosome SII protein 12 and polynucleotides for coding same
11/28/2001	CN1323803A New human protein with the function of inhibiting cancer cell growth and its coding sequence
11/28/2001	CN1323802A New human protein with the function of inhibiting cancer cell growth and its coding sequence
11/28/2001	CN1323801A Simple ferredoxin separating process
11/27/2001	US6324479 Methods of determining protein activity levels using gene expression profiles
11/27/2001	US6323393 Nucleotide sequences for use as tools in genetic engineering
11/27/2001	US6323390 Transgenic mouse models for human bladder cancer
11/27/2001	US6323336 PhoH homolog
11/27/2001	US6323335 Nucleotide sequences coding cell proliferation and differentiation polypeptide; for use in controlling cell proliferation and differentiation; for treating cancer
11/27/2001	US6323334 Nucleic acid molecules encoding a 103 gene product and uses therefor
11/27/2001	US6323333 Mouse EDG1
11/27/2001	US6323331 Beclin-related nucleic acid molecules, and uses thereof
11/27/2001	US6323330 Protein C16 and C16N or genes encoding the same
11/27/2001	US6323329 Nucleic acid sequences of genes encoding high mobility group proteins
11/27/2001	US6323326 Method of solubilizing, purifying, and refolding protein
11/27/2001	US6323324 Test kits for detecting the presence of C-terminal hGPIIb fragments
11/27/2001	US6323323 Ligand-binding, dimerized polypeptide fusions
11/27/2001	US6323322 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
11/27/2001	US6323320 Acellular red blood cell substitute
11/27/2001	US6323319 Method of making hydrolyzed collagen type II
11/27/2001	US6323317 Therapeutic and diagnostics proteins comprising a SOCS box
11/27/2001	US6323316 Nucleotide sequences coding preferential polypeptide for use in diagnosis and detection of tumors
11/27/2001	US6323313 Genetically engineered binding protein for use in diagnosis, detection and treatment of vascular system thrombosis
11/27/2001	US6323312 Cyclic CRF antagonist peptides
11/27/2001	US6323311 Synthesis of insulin derivatives
11/27/2001	US6323198 Cognition activators for gamma-aminobutyric acid binding receptors
11/27/2001	US6323178 Beta-lipotropin methods
11/27/2001	US6323175 Composition comprising physiologically compatible liposome, hemoglobin encapsulated in liposome, and nitroxide encapsulated in liposome
11/27/2001	US6323030 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
11/27/2001	US6323028 Isolated peptides which comply with HLA-CW16 molecules and uses
11/27/2001	US6323027 Common gamma chain monoclonal antibody blocking agents
11/27/2001	US6323026 Mutations in the KCNE1 gene encoding human mink which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene
11/27/2001	US6323024 Plasmids for the expression of heterologus genes; for use in treatment and prevention of viral diseases
11/27/2001	US6323023 Expression vector coding enzymatic polypeptides; for use in adjusting plant morphology
11/27/2001	US6323020 Neutralization-sensitive epitopes of Cryptosporidium parvum
11/27/2001	US6323019 Design of novel highly efficient HIV based packaging systems for gene therapy
11/27/2001	US6323006 Recombinant human beta-CIS interferon
11/27/2001	US6323005 Transferrin-binding protein 1 (TBP1) gene of Actinobacillus pleuropneumoniae, its use to prepare products for the utilization in vaccines for pleuropneumonia and as diagnostic reagents
11/27/2001	US6323001 Increasing the trehalose content of organisms by transforming them with combinations of the structural genes for trehalose synthase
11/27/2001	US6323000 To identify compounds that interact with it
11/27/2001	US6322999 Cloned genes coding for human receptors, and cell lines expressing genes, in order to generate a proper screen for human therapeutic compounds
11/27/2001	US6322996 Reacting a physiologically active protein with an amino group donor or alkylamine-containing polysaccharide in presence of transglutaminase, thereby modifying protein by forming an amido linkage between carboxyamide group of glutamine residue
11/27/2001	US6322990 Methods of identifying agents that block the interaction of a BAP protein with a signaling partner
11/27/2001	US6322978 Repeat polymorphism in the frataxin gene and uses therefore
11/27/2001	US6322977 Tapasin-like protein
11/27/2001	US6322976 Compositions and methods of disease diagnosis and therapy
11/27/2001	US6322972 Detecting suppressors of ligand binding; transform cells, propagate cells, expose to modulator, compare expression of reporter genes in presence and absence of compound, decrease in expression indicates modulators
11/27/2001	US6322967 Recombinant tryptophan mutants of influenza
11/27/2001	US6322965 Chimera antigen peptide
11/27/2001	US6322964 Synthetic HIV-2 gag and env oligopeptides reactive with HIV-2 specific antibodies
11/27/2001	US6322795 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses
11/27/2001	US6322794 Seroreactive epitopes on proteins of human papillomavirus (HPV) 18
11/27/2001	US6322793 Replacement of gene 50 glycoprotein with foreign genetic material
11/27/2001	US6322792 Gamma-2 herpes viruses like kaposi's sarcoma-associated herpes virus useful in modulating persistence of heterologous dna; gene therapy
11/27/2001	US6322791 Haemopoietic growth factor antagonists and uses therefor
11/27/2001	US6322789 Peptide form an epitope-major histocompatibility complex recognized by a cytotoxic t cell and is linked to a lipid; formulated as vaccines; used in diagnostic methods
11/27/2001	US6322786 Growing saos-2 cells, removing culture medium with serum, washing, incubating, collecting culture medium without serum, filtering, obtaining desired retentate
11/27/2001	US6322781 Production of recombinant baculoviruses
11/27/2001	US6322780 Marek's disease virus vaccines for protection against Marek's disease
11/27/2001	US6322779 Purified, unglycosylated endotoxin and pyrogen-free, high specific biological activity; two monomer structure
11/27/2001	CA2240392C Multimer forms of interleukin-16 (il-16), process for the preparation and use thereof
11/27/2001	CA2178004C Indicator cell line for detecting rna viruses and method therefor
11/27/2001	CA2145866C Human calcitonin receptor
11/27/2001	CA2137009C Technetium-99m labeled peptides for imaging
11/27/2001	CA2074837C Methods of producing hybrid g protein-coupled receptors
11/27/2001	CA2063511C Method for producing human serum albumin
11/27/2001	CA2050644C Process for the purification of insulins by chromatography
11/27/2001	CA2021912C Erythropoietin (epo) peptides and antibodies directed against these
11/27/2001	CA1341322C Interleukin-1 inhibitors
11/26/2001	CA2346163A1 Complex for transferring an anionic substance of interest into a cell
11/26/2001	CA2316405A1 Modulation of inflammation by protease products
11/26/2001	CA2308260A1 Blocking cell-division as a therapeutic treatment of pathogenic bacteria
11/26/2001	CA2307705A1 Modulation of inflammation by protease products
11/25/2001	CA2307128A1 Pt32 sperm protein, oocyte cytoplasmic c-yes, and uses thereof
11/24/2001	CA2309236A1 Cross-linked hemoglobins for transport and delivery of nitric oxide
11/24/2001	CA2309235A1 Fusion polypeptides
11/23/2001	CA2309324A1 Gene that imparts selective proliferation activity
11/22/2001	WO2001088533A2 Lipid uptake assays
11/22/2001	WO2001088532A2 Improved assay techniques using nematode worms
11/22/2001	WO2001088203A1 Cloning of rhadinovirus genome and methods for its use
11/22/2001	WO2001088192A2 A method for generating hypermutable organisms
11/22/2001	WO2001088191A1 A novel specific inhibitor of the cyclin kinase inhibitor p21?waf1/cip1¿
11/22/2001	WO2001088167A2 Spike tissue-specific promoter
11/22/2001	WO2001088165A1 Nucleotide sequences coding for signal transduction components involved in plant pathogen defence
11/22/2001	WO2001088163A1 Method for producing recombinant expansins
11/22/2001	WO2001088161A1 Vector for analysing replication mechanism of rna virus and use thereof
11/22/2001	WO2001088159A2 Cd28 synthebody for the modulation of immune responses
11/22/2001	WO2001088154A1 Microglobulin transcription human regulation factor 17
11/22/2001	WO2001088151A1 Novel polypeptide - a human microglobulin transcriptional control factor 30 and polynucleotide encoding it
11/22/2001	WO2001088142A1 A novel polypeptide -human ubiquitin-binding enzyme 9 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001088141A2 Synthetic gagpol genes and their uses

1 ... 1929 1930 1931 1932 1933 1934 1935 1936 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 ... 2916